Francine Shapiro Library - EMDR Bibliography Links
Choose any combination of the search options below. If you do not wish to include an option in your search, leave the box blank, or select "Any."
Your Results - you searched for the keyword Antidepressants 21 Results
1. 이선혜; 김석현; & 김대호 [Lee, Sun Hye, Kim, Seok Hyeon, & Kim, Daeho] (2007). 차 항우울제 치료에 반응 않는 외상후 스트레스 장애의 EMDR 병합 치료 증례 [ Add-on EMDR for posttraumatic stress disorder not responding to initial antidepressant therapy：Case report]. 생물치료정신의학 제13권 제2호, 46 [Journal of the Korean Society of Biological Therapy in Psychiatry, 13(2), 346-351].
Language: Korean
Format: Journal
Abstract:
외상후 스트레스 장애 (PTSD)의 치료 전략에 대한 문학의 성장 본문있다. 그리고 metaanalyses 및 임상 지침 등장으로 진행합니다. CBT 또는 EMDR이 인구에 대한 치료의 첫번째 라인에 대한 권장되었습니다 최근 외상 중심. 그러나, 아주 작은 문학은 약물과 PTSD의 심리 치료의 통합 치료를위한 존재합니다. 이 사건 보고서는 처음 약은 치료에 대응하는 데 실패하지만, EMDR이 추가된 후에 나중에 향상했다 PTSD 두 개인을 소개합니다. 또한 제어 연구는이 찾는 일반화하기 위해 필요합니다.
There is a growing body of literature on the treatment strategy of posttraumatic stress disorder(PTSD). And metaanalyses and clinical guidelines continue to emerge. Recently, trauma-focused CBT or EMDR have been recommended for the 1st line of therapy for this population. However, very little literature exists for combined treatment of medication and psychotherapy in PTSD. This case report introduces two individuals with PTSD, who had initially failed to respond to antidepressant therapy, but later improved after EMDR was added. Further controlled studies are needed to generalize this finding.
Keywords: Antidepressants Combined Treatment Drug Therapy Posttraumatic Stress Disorder PTSD
Accuracy Verified: Yes
2. 이선혜 (저자) ; 김석현 (저자) ; 김대호 (저자) [Yiseonhye; Seok; & Dae-Ho] (2007). 차 항우울제 치료에 반응 않는 외상후 스트레스 장애의 EMDR 병합 치료 증례 [EMDR for posttraumatic stress disorder not responding to initial antidepressant therapy：Case report]. 생물치료정신의학 제13권 제2호, 46 [Biological Treatment of Psychiatry, 13(2), 246].
Language: Korean
Format: Journal
Abstract:
외상후 스트레스 장애 (PTSD)의 치료 전략에 대한 문학의 성장 본문있다. 그리고 metaanalyses 및 임상 지침 등장으로 진행합니다. CBT 또는 EMDR이 인구에 대한 치료의 첫번째 라인에 대한 권장되었습니다 최근 외상 중심. 그러나, 아주 작은 문학은 약물과 PTSD의 심리 치료의 통합 치료를위한 존재합니다. 이 사건 보고서는 처음 약은 치료에 대응하는 데 실패하지만, EMDR이 추가된 후에 나중에 향상했다 PTSD 두 개인을 소개합니다. 또한 제어 연구는이 찾는 일반화하기 위해 필요합니다.
There is a growing body of literature on the treatment strategy of posttraumatic stress disorder(PTSD). And metaanalyses and clinical guidelines continue to emerge. Recently, trauma-focused CBT or EMDR have been recommended for the 1st line of therapy for this population. However, very little literature exists for combined treatment of medication and psychotherapy in PTSD. This case report introduces two individuals with PTSD, who had initially failed to respond to antidepressant therapy, but later improved after EMDR was added. Further controlled studies are needed to generalize this finding.
Keywords: Antidepressants Combined Treatment Drug Therapy Posttraumatic Stress Disorder PTSD
Accuracy Verified: No
3. Forbes, D., Creamer, M., Phelps, A., Bryant, R., McFarlane, A., Devilly, G. J., Lynda Matthews, L., Raphael, B., Doran, C., Merlin, T., & Skye N. (2007, August). Australian guidelines for the treatment of adults with acute stress disorder and post-traumatic stress disorder. Australian & New Zealand Journal of Psychiatry, 41(8), 637-648. doi:10.1080/00048670701449161.
Language: English
Format: Journal
Abstract:
Over the past 2-3 years, clinical practice guidelines (CPGs) for post-traumatic stress disorder (PTSD) and acute stress disorder (ASD) have been developed in the USA and UK. There remained a need, however, for the development of Australian CPGs for the treatment of ASD and PTSD tailored to the national health-care context. Therefore, the Australian Centre for Posttraumatic Mental Health in collaboration with national trauma experts, has recently developed Australian CPGs for adults with ASD and PTSD, which have been endorsed by the National Health and Medical Research Council (NHMRC). In consultation with a multidisciplinary reference panel (MDP), research questions were determined and a systematic review of the evidence was then conducted to answer these questions (consistent with NHMRC procedures). On the basis of the evidence reviewed and in consultation with the MDP, a series of practice recommendations were developed. The practice recommendations that have been developed address a broad range of clinical questions. Key recommendations indicate the use of trauma-focused psychological therapy (cognitive behavioural therapy or eye movement desensitization and reprocessing in addition to in vivo exposure) as the most effective treatment for ASD and PTSD. Where medication is required for the treatment of PTSD in adults, selective serotonin re-uptake inhibitor antidepressants should be the first choice. Medication should not be used in preference to trauma-focused psychological therapy. In the immediate aftermath of trauma, practitioners should adopt a position of watchful waiting and provide psychological first aid. Structured interventions such as psychological debriefing, with a focus on recounting the traumatic event and ventilation of feelings, should not be offered on a routine basis. [InformaWorld]
Keywords: ASD Guidelines Posttraumatic Stress Disorder PTSD Trauma Treatment
Accuracy Verified: Yes
4. Australian Centre for Posttraumatic Mental Health (2007, February). Australian Guidelines for the treatment of Adults with Acute Stress disorder and posttraumatic stress disorder. Melbourne, Victoria: ACPMH.
Language: English
Format: Other
Abstract:
The Australian Centre for Posttraumatic Mental Health in collaboration with national trauma experts, has recently developed Australian CPGs for adults with ASD and PTSD, which have been endorsed by the National Health and Medical Research Council (NHMRC). In consultation with a multidisciplinary reference panel (MDP), research questions were determined and a systematic review of the evidence was then conducted to answer these questions (consistent with NHMRC procedures). On the basis of the evidence reviewed and in consultation with the MDP, a series of practice recommendations were developed. The practice recommendations that have been developed address a broad range of clinical questions. Key recommendations indicate the use of trauma-focused psychological therapy (cognitive behavioural therapy or eye movement desensitization and reprocessing in addition to in vivo exposure) as the most effective treatment for ASD and PTSD. Where medication is required for the treatment of PTSD in adults, selective serotonin re-uptake inhibitor antidepressants should be the first choice. Medication should not be used in preference to trauma-focused psychological therapy. In the immediate aftermath of trauma, practitioners should adopt a position of watchful waiting and provide psychological first aid. Structured interventions such as psychological debriefing, with a focus on recounting the traumatic event and ventilation of feelings, should not be offered on a routine basis. [InformaWorld]
Keywords: Treatment Guidelines
Accuracy Verified: Yes
5. Aurora, R. N., Zak, R. S., Auerbach, S. H., Casey, K. R., Chowdhuri, S., Karippot, A., Maganti, R. K., Ramar, K., Kristo, D. A., Bista, S. R., Lamm, C. I., & Morgenthaler, T. I. (2010, August). Best practice guide for the treatment of nightmare disorder in adults. Journal of Clinical Sleep Medicine, 6(4), 389-401.
Language: English
Format: Journal
Abstract:
Prazosin is recommended for treatment of Posttraumatic Stress Disorder (PTSD)-associated nightmares. Level A. Image Rehearsal Therapy (IRT) is recommended for treatment of nightmare disorder. Level A. Systematic Desensitization and Progressive Deep Muscle Relaxation training are suggested for treatment of idiopathic nightmares. Level B. Venlafaxine is not suggested for treatment of PTSD-associated nightmares. Level B. Clonidine may be considered for treatment of PTSD-associated nightmares. Level C. The following medications may be considered for treatment of PTSD-associated nightmares, but the data are low grade and sparse: trazodone, atypical antipsychotic medications, topiramate, low dose cortisol, fluvoxamine, triazolam and nitrazepam, phenelzine, gabapentin, cyproheptadine, and tricyclic antidepressants. Nefazodone is not recommended as first line therapy for nightmare disorder because of the increased risk of hepatotoxicity. Level C. The following behavioral therapies may be considered for treatment of PTSD-associated nightmares based on low-grade evidence: Exposure, Relaxation, and Rescripting Therapy (ERRT); Sleep Dynamic Therapy; Hypnosis; Eye-Movement Desensitization and Reprocessing (EMDR); and the Testimony Method. Level C. The following behavioral therapies may be considered for treatment of nightmare disorder based on low-grade evidence: Lucid Dreaming Therapy and Self-Exposure Therapy. Level C No recommendation is made regarding clonazepam and individual psychotherapy because of sparse data.
Keywords: Nightmares Posttruamatic Stress Disorder PSTD
Accuracy Verified: Yes
6. Cartwright, L. (2000, September-October). Case Studies: Expanding our tool kit: A new technique that compliments TFT and EMDR. Family Therapy Networker, 24(5), 71-82.
Language: English
Format: Magazine
Abstract:
In recent years, increasing numbers of therapists have discovered the effectiveness of neurologically based therapy techniques, such as Eye Movement Desensitization and Reprocessing (EMDR) and Thought Field Therapy (TFT), not only for trauma, but for a wide range of problems, including anxiety, anger, grief and phobias. Like most therapeutic approaches, however, they provide remarkable results for one client and little or no results for another, no matter how skilled the therapist. Even more mysterious, they can significantly help a client with one problem, but not with a different problem. For instance, Sarah, age 40, had been suffering from depression for five years. The depression was triggered by the death of her father, loss of a good-paying job due to downsizing and her fiance's breaking off their engagement--all within a one-year period. After six months of increasing anxiety and worsening depression (accompanied by low energy, disinterest in life and withdrawal from social situations), Sarah entered therapy. Biweekly sessions for the next three years, which frequently included EMDR, significantly reduced her anxiety, but did not alleviate the depression. Nor did antidepressants. Years before, I had had a similar experience. EMDR had sharply reduced my obsessive-compulsive symptoms, but didn't help my depression. TFT eliminated recurring anger, but also didn't help my depression.
In the course of five years of research into neurologically based approaches, I happened upon a working hypothesis that explains such inconsistent results. The side-to-side eye movements of EMDR that activate the left and right hemispheres of the brain seem to help people resolve problems based on a lack of communication between the left and right hemispheres of the brain. The tapping, or front/back stimulation of acupuncture points, in TFT is effective when there is a lack of communication between the front and back of the nervous system (controlled by the energy center, well known to acupuncturists and martial artists, that lies below the navel). And since we are three-dimensional creatures, I hypothesized that some problems stem from a lack of communication between the top and bottom of the nervous system as well, which I correlate with the brain and the enteric nervous system of the digestive tract (the source of gut feelings). Working from this hypothesis, I have also developed processes to reintegrate the top/bottom dimension.
I have found that although certain emotions tend to be based within a given neurological dimension (indecisiveness is often in left/right, anxiety in front/back and depression in top/bottom, for example), a client may experience any emotion as a block within any dimension or combination of dimensions. As a result, depending upon both the client and the specific problem being addressed, a therapist might need to use techniques that facilitate integration of the left/right, front/back and/or top/bottom dimensions of the nervous system. When a client is blocked within two or three dimensions of the nervous system, working within just one dimension will sometimes activate healing across the entire nervous system. If this does not happen, it is then necessary to work in the remaining dimensions.
From these hypotheses I developed a system called Shifting Consciousness through Dimensions (SCtD), which provides therapists ways to assess the dimension(s) the client is blocked in, processes to identify, if necessary, which dimension to start with and specific integrating techniques for each dimension.
Keywords: TFT Thought Field Therapy
Accuracy Verified: Yes
7. McFarlane, A. (2003, October-November). CBT vs. EMDR in the treatment of PTSD. In B. A. van der Kolk (Chair), Treatment outcome studies of PTSD. Symposium conducted at the 19th annual meeting of the International Society for Traumatic Stress Studies, Chicago, IL .
Language: English
Format: Conference
Abstract:
Treatment Outcome Studies of PTSD: This symposium presents three large carefully controlled treatment
outcome studies using four different treatment modalities (CBT,
EMDR, psychopharmacology and Cognitive Processing) and presents
data on comparative efficacy, treatment responsiveness and
resistance, effects on comorbidity, quality of life, and biological
changes that accompany symptom improvement.
CBT vs. EMDR in the treatment of PTSD: 114 subjects were randomized into the study, but only 45 completed
up to week 10. The subjects in the study comprise 45 sufferers of
Post traumatic stress disorder as defined by the Clinician
Administered PTSD Scale (CAPS) (caps score > 50, and who satisfied
criteria A,B,C and D for PTSD diagnosis) and the PCL-C (PCL-C>50).
All subjects were victims of a traumatic experience and were
recruited through newspaper or radio advertisements, referrals from
private practitioners (18 subjects) or through the State Government
Insurance Commission (SGIC) (27 subjects). Subjects were randomised
into one of three treatments. Fourteen subjects received
EMDR, 21 received CBT and 10 were control subjects. The mean
age of the sample was 41.38 (SD=11.55) with the minimum age of
19 and the maximum age of 61. Sixteen of the subjects were male
and 29 were female. During the treatment period 17 of the subjects
were taking antidepressants and 6 were taking anxiolytics.
Approximately half of the sample was married (22 subjects 48.9%),
12 had never married, 4 were separated, 1 was defacto and 6 were
divorced. The mean number of treatment sessions for the entire
sample was 8.53 (SD 1.65). Out of the 45 participants in the study, 26
had suffered only one single trauma in their lives, 11 had experienced
several single traumas, 3 had suffered one ongoing trauma
and 5 individuals had suffered at least one ongoing and one specific
trauma. The following results were performed on the treatment
groups (total 35 subjects), with the control group being excluded
from all analyses. All subjects, were aged between 18 and 65, lived
in metropolitan Adelaide and had an adequate command of
English (reading and writing).All subjects gave informed consent to
the study and expressed their willingness to comply with the protocol.
Subjects with a history of adult seizure disorder, organic brain
disease or who were assessed to be at significant suicide risk (a
score of 3 or more on suicide question in HAM-D), were excluded
from the study, as were subjects taking psychotropic drugs (anticonvulsive/
antipsychotic) or sedatives more than 4 times a week. All
assessment and treatment sessions were conducted at the
University of Adelaide Department of Psychiatry at the Queen
Elizabeth Hospital. Assessment sessions were conducted by trained
research assistants and all therapy sessions were conducted by a
clinical psychologist, trained in both EMDR and CBT. Subjects were
assessed for suitability to enter the study via an initial screening
instrument (sent out to subjects in the post) and an initial screening
interview. Patients were further evaluated at week 0
(baseline/immediately prior to commencement of treatment), 3, 4,
6, 8 10, 20 (10 week followup).
Keywords: CBT Cognitive Behavioral Therapy Symposium
Accuracy Verified: Yes
8. Otto, M. W., Penava, S. J., Pollack, R. A., & Smoller, J. W. (1996). Cognitive-behavioral and pharmacologic perspectives on the treatment of posttraumatic stress disorder. In M. H. Pollack, M. W. Otto, & J. F. Rosenbaum (Eds.). Challenges in clinical practice: Pharmacologic and psychosocial strategies (pp. 219-260). New York: Guilford Press.
Language: English
Format: Book Section
Abstract:
The following sections consider biologic and cognitive-behavioral perspectives on PTSD and strategies for its treatment. Pharmacologic strategies examined to date have included treatment with beta-adrenergic blockers and alpha-adrenergic agonists, benzodiazepines, antikindling agents, mood stabilizers, and various antidepressants. Exposure-based treatments have been included in a number of approaches to the disorder, but have received the most direct attention in cognitive-behavioral conceptualizations. Each of these interventions has the potential to change one aspect or a constellation of PTSD symptoms, and must be evaluated relative to the number of symptom domains that each affects. [Text, p. 222]
Keywords: Behavior Therapy Cognitive Therapy Drug Therapy Literature Review Neurobiology Psychopharmacology PTSD Stressors Survivors Treatment Effectiveness
Accuracy Verified: Yes
9. St-André, E. (2009, August). EMDR and OCD. Presentation at the annual meeting of the EMDR International Association, Atlanta, GA.
Language: English
Format: Conference
Abstract:
Obsessive Compulsive Disorder (OCD) is a chronic illness with recurrent obsessions, persistent thoughts and compulsions, such as repetitive behaviors that are performed after obsessions. Current treatment for such a disorder includes antidepressants (SSRI, with additional treatment such as antipsychotics) and psychotherapy, usually cognitive behavioral approaches. Nevertheless, there is a lack of available evidence for the long-term effectiveness of psychological treatment (Cochrane Reviews on OCD treatment will be cited). EMDR can be useful in a severe case of OCD and might be of interest for other therapists struggling with OCD cases in their caseload.
Keywords: Obsessive Compulsive Disorder OCD
Accuracy Verified: Yes
10. Jones, J. (1995, June). EMDR: A candid view from the psychiatrist's couch. Presentation at the EMDR Network Conference, Santa Monica, CA .
Language: English
Format: Conference
Abstract:
I will attempt to present an overview of the major psychiatric disorders, some medical and neurologic syndromes and general concepts on how I approach diagnosis, prognosis and treatment. Our time will include all this and put special focus on psychpharmacology. The nature and scope of this material will be mostly introductory but i will certainly be open to exploring my topic at greater depth depending the needs of the group present. The audience should be any among you who would likea way to begin organizing you approach to pharmacology and the impact that is having on your practice and the use of EMDR. Licensed clinical social workers, marriage and family counselors and psychologists should especially benefit form the discussion. You can expect to hear about major depression and its variants, bipolar disorder, panic disorder and the general anxiety disorders- some coverage of eating disorders, PTSD and adult attention deficit disorder but in less detail. I shall only touch upon schzophrenia and the psychotic disorders unless you show a special interest. The same is true for medical and neurologic diagnosis which have psychotic sequelas. I shall then to proceed to describe the differences and similarities among the antidepressants following that with a less detailed presentation of anit-anxiety agents, anti-psychotics, lithium and its siblings and a few of the "tried-and-true" substances of abuse like alcohol, stimulants, hallucinogens and narcotics. Please forgive me if I draw the line at designer drugs. This is a vast amount of information. I shall empasize general organizing concepts which will help the clinician who would like to understand some of his/her clients better, know better when to make a referral to a psychiatrist, now some of the potentials and limitations of EMDR when your clients are taking medications and/or have a major psychiatric disorder. Do not come to if you wish to set sail on a sea of psychiatric and medical details - 90 minutes just will not suffice! I will depend on you to speak up at any time with your concerns and queries (not to mention contradictions) so we can tailor the moment to the real interests of those present. I will attempt to reserve a substantial amount of time for question, answers, and observations but, if we are lucky, this will be happening throughout the ninety minutes. If we have time left I will explore the subject of "you and your psychiatrist" with both panache and hubris. We have a reputation for not being the most ingratiating of colleagues. I have a number of suggestions from a psychiatrist perspective which could make it easier to manage (sic) your psychiatrist. I hope we will be able to conclude with some high spirits and as they say here in California, a time for sharing and mutual understanding.
Accuracy Verified: Yes
11. Butler, A. C., Chapman, J. R., Forman, E. M., & Beck, A. T. (2006, January). The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review, 26(1), 17-31. doi:10.1016/j.cpr.2005.07.003.
Language: English
Format: Journal
Abstract:
This review summarizes the current meta-analysis literature on treatment outcomes of CBT for a wide range of psychiatric disorders. A search of the literature resulted in a total of 16 methodologically rigorous meta-analyses. Our review focuses on effect sizes that contrast outcomes for CBT with outcomes for various control groups for each disorder, which provides an overview of the effectiveness of cognitive therapy as quantified by meta-analysis. Large effect sizes were found for CBT for unipolar depression, generalized anxiety disorder, panic disorder with or without agoraphobia, social phobia, PTSD, and childhood depressive and anxiety disorders. Effect sizes for CBT of marital distress, anger, childhood somatic disorders, and chronic pain were in the moderate range. CBT was somewhat superior to antidepressants in the treatment of adult depression. CBT was equally effective as behavior therapy in the treatment of adult depression and obsessive-compulsive disorder. Large uncontrolled effect sizes were found for bulimia nervosa and schizophrenia. The 16 meta-analyses we reviewed support the efficacy of CBT for many disorders. While limitations of the meta-analytic approach need to be considered in interpreting the results of this review, our findings are consistent with other review methodologies that also provide support for the efficacy CBT. [Author Abstract]
Keywords: Cognitive Therapy Literature Review Meta Analysis Posttraumatic Stress Disorder PTSD Stressors Survivors Treatment Effectiveness
Accuracy Verified: Yes
12. Berthon, C. (2008). Evaluation des souvenirs traumatiques dans les troubles phobiques et perspectives thérapeutiques en EMDR [Evaluation of traumatic memories in phobic disorders and therapeutic perspectives in EMDR]. Université de Versailles-Saint-Quentin-en-Yvelines, Versailles, France.
Language: French
Format: Dissertation/Thesis
Abstract:
Les phobies sont des pathologies fréquentes dont l'étiopathogénie est multifactorielle. Actuellement, le traitement repose essentiellement sur les antidépresseurs et sur la thérapie cognitivo-comportementale (TCC). L'EMDR (Eye-Movement Desensitization and Reprocessing) semble efficace dans le traitement des phobies et ce d'autant plus qu'une composante traumatique est présente. Cette thérapie pourrait donc constituer une alternative intéressante aux TCC. Cependant, il n'existe à ce jour aucun outil pour sélectionner les candidats à l'EMDR. Nous avons mis au point une échelle d'hétéro-évaluation permettant de calculer un score total d'impact de souvenirs potentiellement traumatiques. Cet outil est testé chez 29 patients. Notre étude permet de confirmer la pertinence et la faisabilité d'une telle évaluation des souvenirs traumatiques. En effet, cette échelle a d'une part un intérêt étiopathogénique (évaluation de la dimension traumatique dans les phobies) et d'autre part un intérêt thérapeutique.
Phobias are common diseases whose pathogenesis is multifactorial. Currently, treatment is based primarily on antidepressants and cognitive-behavioral therapy (CBT). EMDR (Eye Movement Desensitization and Reprocessing-) appears to be effective in the treatment of phobias and even more traumatic one component is present. This therapy could therefore be an interesting alternative to CBT. However, there is currently no tool to select candidates for EMDR. We developed a scale of hetero-assessment to calculate a total score impact potentially traumatic memories. This tool has been tested in 29 patients. Our study confirms the relevance and feasibility of such an assessment of traumatic memories. Indeed, this scale has a share interest etiopathogenic (assessment in phobias traumatic dimension) and other therapeutic interest.
Accuracy Verified: Yes
13. Hudson, J., Chase, E., & Pope, H. (1998, January). Eye movement desensitization and reprocessing in eating disorders: Caution against premature acceptance. International Journal of Eating Disorders, 23(1), 1-5. doi:10.1002/(SICI)1098-108X(199801)23:1<1::AID-EAT1>3.3.CO;2-P.
Language: English
Format: Journal
Abstract:
Objective: Eye movement desensitization and reprocessing (EMDR) has been claimed effective in the treatment of a wide variety of psychiatric disorders, including eating disorders. An informal survey suggests that EMDR is now widely offered to patients with eating disorders. Before accepting a new therapy such as EMDR, one must determine that its benefits outweigh its adverse effects. This paper reviews the literature in an attempt to assess the benefits and risks of the use of EMDR in the treatment of eating disorders. Method: We reviewed the literature on the use of EMDR to treat eating disorders and other conditions. Results: Looking at the question of its benefits, we were unable to find any methodologically sound studies that have shown efficacy for EMDR in eating disorders, or, indeed, any psychiatric disorder. We were also unable to find a sound theoretical basis for expecting EMDR to be effective. In addition, EMDR may have adverse effects. First, EMDR is sometimes used in conjunction with efforts to "recover" memories of traumatic events. But "recovered memory" therapy may carry a risk of inducing potentially harmful false memories. Second, use of EMDR may prevent or delay other therapies of established efficacy for eating disorders, such as cognitive behavioral therapy and antidepressants. Discussion: In light of the findings of our review, the risk/benefit ratio of EMDR does not as yet encourage its widespread acceptance.
Keywords: Eating Disorders Literature Review
Accuracy Verified: Yes
14. Staff. (2007, June). The latest, greatest treatments for PTSD. Carlat Psychiatry Report, 5(6). Retrieved from http://www.thecarlatreport.com/index.asp?page=wp530200711859 12/8/2007.
Language: English
Format: Newsletter
Abstract:
At least in Britain, it’s official: psychotherapy works better than medication for PTSD. You shouldn’t be too surprised. The last time we covered PTSD (TCPR April 2004) we reviewed the SSRIs and found them to have evidence of only modest efficacy.
Now, according to the latest treatment guidelines from Britain's National Institute for Clinical Excellence (NICE), antidepressants are no longer recommended as a first-line treatment, but cognitive therapy is. You can check out these guidelines for free at http://guidance.nice.org.uk/CG26/guidance/pdf/English.
Accuracy Verified: Yes
15. Bryant, R. A., & Friedman, M. J. (2001, March). Medication and non-medication treatments of post-traumatic stress disorder. doi:10.1097/00001504-200103000-00004. Current Opinion in Psychiatry, 14(2), 119-123. doi:10.1097%2F00001504-200103000-00004.
Language: English
Format: Journal
Abstract:
Recent developments in the psychological and pharmacological management of post-traumatic stress disorder are reviewed. This review of controlled outcome studies indicates that: (i) cognitive behavior therapy is the psychological treatment of choice; (ii) different components of cognitive behavior therapy can be effective; (iii) eye movement desensitization and reprocessing is not as effective as cognitive behavior therapy; (iv) selective serotonin re-uptake inhibitors are the pharmacological treatment of choice; and (v) there is increasing support for nefazadone but not for cyproheptadine in reducing the symptoms of post-traumatic stress disorder. The need for increased treatment effectiveness and the integration of recent findings into clinical practice is discussed. [Author Abstract]
Keywords: Atypical Antidepressants Cognitive Therapy Drug Therapy Literature Review Posttraumatic Stress Disorder PTSD Selective Serotonin Reuptake Inhibitors Treatment Treatment Effectiveness
Accuracy Verified: Yes
16. Cooper, G. (2007, January-February). A more powerful antidepressant. Psychotherapy Networker, 31(1), 19-22.
Language: English
Format: Magazine
Abstract:
Cooper discusses current trends in mental health treatment. Among the topics explored are effective versus discredited therapies, antidepressants, and appropriate treatment for chronic fatigue syndrome.
Keywords: Antidepressants Chronic Fatigue Syndrome Mental Health Care Medical Treatment
Accuracy Verified: Yes
17. Kapfhammer, H.-P. (2008, December). Therapeutische möglichkeiten nach traumatischen erlebnissen [Therapeutic possibilities after traumatic experiences]. Psychiatria Danubina, 20(4), 532-545.
Language: German
Format: Journal
Abstract:
Acute Belastungsstörung (ASD) und Posttraumatische Belastungsstörung (PTSD) sind häufige, aber nicht zwingend psychologische Folgeerscheinungen nach einem Trauma. Eine wichtige Untergruppe der Patienten vor einer chronischen Verlauf der Erkrankung mit einem erhöhten psychiatrischen Komorbidität und erhebliche Beeinträchtigungen in psychosozialen Anpassung assoziiert. Der typische psychopathologische Symptome von ASD und PTSD werden am besten in einem multifaktoriellen Modell der Integration sowohl neurobiologische und psychosoziale Einflüsse beschrieben. Die komplexen Ätiopathogenese von akuten und posttraumatischen Belastungsstörung begünstigt multimodalen Ansätzen in der Behandlung. Differential psychotherapeutische und pharmakologische Strategien zur Verfügung stehen. In einer kritischen Studie über empirische Studien, können psychologische Debriefing nicht als einen positiven Ansatz betrachtet werden, als allgemeine vorbeugende Maßnahme in der unmittelbaren posttraumatischen Phase empfohlen werden. Positive Auswirkungen der kognitiv-verhaltenstherapeutischen Interventionen kann für ASD eingerichtet werden. Psychodynamische Psychotherapie, kognitive Verhaltenstherapie und EMDR zeigen viel versprechende Ergebnisse bei der Behandlung von PTSD. Wesentliche klinische Einschränkungen der Patienten innerhalb von speziellen Probenahmen Forschungseinrichtungen, jedoch nicht gestatten, eine bedingungslose Verallgemeinerung dieser Daten zu psychiatrischen Routineversorgung. In einer empirischen Analyse der SSRIs sind die meisten und am besten untersuchten Medikamente für ASD und PTSD. Im Vergleich zu trizyklischen Antidepressiva SSRIs zeigen ein breiteres Spektrum an therapeutischen Wirkungen und sind besser verträglich. Die Substanzklassen der SNRI, DAS, SARI und NaSSA sind als Medikamente der zweiten Wahl angesehen werden. Sie versprechen eine therapeutische Wirksamkeit der SSRI gleichwertig, wobei bisher nur in offenen Studien untersucht. MAO-Hemmer können eine positive therapeutische Potenzial verfügen, müssen ihr Profil der Nebenwirkungen geachtet, jedoch werden. Mood-Stabilisatoren und atypische Neuroleptika können in Anspruch genommen werden und vor allem im Add-On-Strategien. Benzodiazepine sollten nur mit Vorsicht erhöht für eine kurze Zeit in den Staaten der akuten Krise eingesetzt werden. In frühen Interventionen, die blockierende Substanzen norepinephric Hyperaktivität scheinen vielversprechende Alternativen. Stress Dosen von Hydrocortison kann als experimentelle pharmakologische Strategie betrachtet so weit sein. [PubMed]
Acute stress disorder (ASD) and posttraumatic stress disorder (PTSD) are frequent, but not obligatory psychological sequelae following trauma. A major subgroup of patients face a chronic course of illness associated with an increased psychiatric comorbidity and significant impairments in psychosocial adaptation. The typical psychopathological symptoms of ASD and PTSD are best described within a multifactorial model integrating both neurobiological and psychosocial influences. The complex etiopathogenesis of acute and posttraumatic stress disorder favours multimodal approaches in the treatment. Differential psychotherapeutic and pharmacological strategies are available. In a critical survey on empirical studies, psychological debriefing cannot be considered as a positive approach to be recommended as general preventive measure during the immediate posttraumatic phase. Positive effects of cognitive-behavioral interventions can be established for ASD. Psychodynamic psychotherapy, cognitive-behavioral therapy and EMDR show promising results in the treatment of PTSD. Major clinical restrictions of patient sampling within special research facilities, however, do not allow an unconditional generalization of these data to psychiatric routine care. In an empirical analysis the SSRIs are the most and best studied medications for ASD and PTSD. In comparison to tricyclic antidepressants SSRIs demonstrate a broader spectrum of therapeutic effects and are better tolerated. The substance classes of SSNRI, DAS, SARI and NaSSA are to be considered as drugs of second choice. They promise a therapeutic efficacy equivalent to the SSRIs, being investigated so far only in open studies. MAO-inhibitors may dispose of a positive therapeutic potential, their profile of side effects must be respected, however. Mood stabilizers and atypical neuroleptics may be used first and foremost in add-on strategies. Benzodiazepines should be used only with increased caution for a short time in states of acute crisis. In early interventions, substances blocking the norepinephric hyperactivity seem to be promising alternatives. Stress doses of hydrocortisone may be considered as an experimental pharmacological strategy so far.[PUBMED]
Keywords: Acute Stress Disorder ASD Posttraumatic Stress Disorder PTSD
Accuracy Verified: Yes
18. Forbes, D., Creamer, M. C., Phelps, A. J., Couineau, A. L., Cooper, J. A., Bryant, R. A., McFarlane, A. C., Devilly, G. J., Matthews, L. R., & Raphael, B. (2007, July). Treating adults with acute stress disorder and post-traumatic stress disorder in general practice: A clinical update. Medical Journal of Australia, 187(2), 120-123.
Language: English
Format: Journal
Abstract:
General practitioners have an important role to play in helping patients after exposure to severe psychological trauma. In the immediate aftermath of trauma, GPs should offer "psychological first aid", which includes monitoring of the patient's mental state, providing general emotional support and information, and encouraging the active use of social support networks, and self-care strategies. Drug treatments should be avoided as a preventive intervention after traumatic exposure; they may be used cautiously in cases of extreme distress that persists. Adults with acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) should be provided with trauma-focused cognitive behaviour therapy (CBT). Eye movement desensitisation and reprocessing (EMDR) in addition to in-vivo exposure (confronting avoided situations, people or places in a graded and systematic manner) may also be provided for PTSD. Drug treatments should not normally replace trauma-focused psychological therapy as a first-line treatment for adults with PTSD. If medication is considered for treating PTSD in adults, selective serotonin reuptake inhibitor antidepressants are the first choice. Other new generation antidepressants and older tricyclic antidepressants should be considered as second-line pharmacological options. Monoamine oxidase inhibitors may be considered by mental health specialists for use in people with treatment-resistant symptoms.
Keywords: Acute Stress Disorder Anti-Depressants ASD MAO Inhibitors Posttraumatic Stress Disorder PSTD SSRIs
Accuracy Verified: Yes
19. Fisher, N. (2010, April). Treatment options for combat veterans with PTSD. Poster presented at the 2nd Bi-Annual International European Society for Trauma and Dissociation Conference, Belfast, Northern Ireland.
Language: English
Format: Conference
Abstract:
In this review I explored the most effective treatment options available for military veterans with Post Traumatic Stress Disorder. Specifically, psychotherapy and pharmacotherapy was examined. Psychotherapy encompassed cognitive behavioral therapy, emotional desensitization and reprocessing and exposure therapy. Pharmacotherapy included selective serotonin reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, novel antidepressants and benzodiazepines. Meta analyses, literature reviews and research experiments formed the basis for the comparisons between treatments. The main findings include that the psychotherapies cognitive behavioral therapy and eye movement desensitization and reprocessing, and the pharmacotherapy selective serotonin reuptake inhibitors are the most superior treatments for veterans with PTSD.
Learning Outcomes
Delegates will learn about the variables which make treating combat veterans with PTSD different than other groups with PTSD. In terms of treatment, psychotherapeutic and psychopharmacologic options will be examined. Delegates will leave the presentation aware of what current research states on treatment efficacy of CBT, EMDR, Exposure Therapy, Antidepressants and Anxiolytics.
Keywords: Poster Posttraumatic Stress Disorder PSTD Veterans
Accuracy Verified: Yes
20. van Vliet, I. M. (2010, April). Update van de multidisciplinaire richtlijn angststoornissen [Multidisciplinary guideline update anxiety]. Presentatie op het 38ste Voorjaarscongres Nederlandse Vereniging voor Psychiatrie, Maastricht, The Nederlands.
Language: Dutch
Format: Conference
Abstract:
Een herziening van de Multidisciplinaire richtlijn Angststoornissen is nodig in verband met nieuwe wetenschappelijke kennis over effectieve interventies en wijzigingen in de organisatie van de zorg.
Doel: De belangrijkste veranderingen van de herziening van de richtlijnen Paniekstoornis met of zonder agorafobie en Posttraumatische stressstoornis worden besproken alsmede implicaties voor de praktijk.
Methoden: De wetenschappelijke literatuur met betrekking tot de paniekstoornis met of zonder agorafobie en posttraumatische stressstoornis werd vanaf 2001 verzameld, beoordeeld en verwerkt in de herziene versie van de richtlijn.
resultaten Bij de paniekstoornis met of zonder agorafobie is de grootste verandering ten opzichte van de eerste versie van de richtlijn dat de combinatiebehandeling van antidepressiva met exposure in vivo niet meer de meest effectieve behandeling is bij ernstige agorafobie. Bij korter bestaande en lichtere vormen van de aandoening gaat de voorkeur uit naar cognitieve gedragstherapie of daarop gebaseerde interventies. Bij de posttraumatische stressstoornis is de belangrijkste verandering dat cognitieve gedragstherapie en eye movement desensitization and reprocessing (emdr) nog meer dan in de eerste versie van de richtlijn geprioriteerd zijn als behandeling van eerste voorkeur. De nieuwe behandelalgoritmes worden besproken.
Conclusie: De nieuwe richtlijn geeft aanwijzingen voor een stepped-care behandeling van angststoornissen. Meer nadruk is gegeven aan niet-medicamenteuze behandelvormen. medicamenteuze behandelingen worden gereserveerd voor de meer langdurige, ernstige en voor psychotherapie resistente angststoornissen alsmede voor angststoornissen met een comorbide ernstige depressieve stoornis.
A review of the Anxiety Disorders Multidisciplinary guideline is necessary because of new scientific knowledge about effective interventions and changes in the organization of care.
Purpose: The main changes from the revision of the guidelines Panic Disorder with or without agoraphobia, and posttraumatic stress disorder are discussed and implications for practice.
Methods: The scientific literature on panic disorder with or without agoraphobia, and posttraumatic stress disorder since 2001 were collected, assessed and reflected in the revised version of the directive.
Results In the panic disorder with or without agoraphobia is the biggest change from the first version of the directive that the combination treatment of antidepressants with exposure in vivo no longer the most effective treatment for severe agoraphobia. For existing shorter and milder forms of the disease is preferable to cognitive behavioral therapy or interventions based thereon. In the post-traumatic stress disorder is the most important change that cognitive behavioral therapy and Eye Movement Desensitization and Reprocessing (EMDR) more than in the first version of the directive are prioritized for treatment of first choice. The new treatment algorithms are discussed.
Conclusion: The new directive gives instructions for a stepped-care treatment of anxiety disorders. More emphasis is given to non-pharmacological treatment modalities. drug treatments are reserved for the more prolonged, severe and resistant to psychotherapy for anxiety disorders and anxiety disorders with a comorbid major depressive disorder.
Keywords: Anxiety Multidisplinary Guideline
Accuracy Verified: Yes
21. van Ommeren, M. (2013, June). WHO guidelines for mental disorders and problems specifically related to stress. Keynote presented at the annual meeting of the EMDR Europe Association, Geneva, Switzerland.
Language: English
Format: Conference
Abstract:
The WHO’s recently completed guideline “Problems and Disorders Specifically Related to Stress” was developed to address the absence of suitable, evidence-based WHO guidelines for managing problems and disorders.
The presentation will include an introduction to the guideline, its rationale and methods. It will discuss the WHO recommendations for CBT, EMDR, stress management and antidepressants for PTSD. The presentation will emphasize challenges and opportunities for EMDR research and practice.
Keywords: Keynote WHO Guidelines
Accuracy Verified: Yes